baber/WOPTO huggingface dataset:
Patent NZ-500373-A (NZ)
Title: Microelectronic device with electrodes with permeation layers for electrolytic transport of species
Inventor: HELLER MICHAEL J
IPC: C12Q1/68
Filed: 1994-10-26
Abstract: An electronic analysis device is can be immersed in a solution of electrolytes and one or more charged specific binding entities and includes a substrate, a selectively addressable current receiving electrode 62 supported by the substrate, a permeation layer disposed adjacent the selectively addressable electrode, an attachment layer adjacent the permeation layer, and a second electrode that is electrically insulated from the first electrode prior to the application of the solution.  The permeation layer provides preferential passage from the solution to the electrode of the electrolytes relative to the charged specific binding entities and permits free transport of ions through the permeation layer in both the presence and absence of specific binding entities to permit the electrophoretic transport of the specific binding entities
Patent NZ-503167-A (NZ)
Title: Pesticide dispersant having a composite dispersing agent containing an alkyl polyglycoside and a polymeric anionic dispersant
Inventor: LUNDSTEDT ALAN P
IPC: C09K23/00
Filed: 1999-07-02
Abstract: A composite dispersing agent comprises an alkyl polyglycoside and a polymeric anionic dispersant. The alkyl polyglycoside can have the formula (I) R1-O-(R2O)b(Z)a wherein: R1 is a monovalent organic radical of 6 to 30 carbons; R2 is a divalent alkylene radical of 2 to 4 carbons; Z is a saccharide of 5 or 6 carbons; b is 0 to 12 and a is 1 to 6. The polymeric anionic dispersant can be a sulphonated lignin.  The agent can also contain a nonionic, anionic, cationic or amphoteric surfactant such as a naphthalene sulphonate. A composition containing a pesticide and a composite dispersing agent as defined above is disclosed.
Patent NZ-503175-A (NZ)
Title: A method of diagnosing lung damage by measuring SP-A, SP-B, SP-C and SP-D levels
Inventor: DOYLE IAN ROSS
IPC: G01N33/68
Filed: 1998-09-04
Abstract: A method of diagnosing lung damage in a mammal wherein the method comprises screening for the modulation of the levels of any one or more of SP-A, SP-B, SP-C or SP-D in the body fluid of the mammal.
Patent NZ-504432-A (NZ)
Title: Use of lysophosphatidylethanolamine (18:1) and lysophosphatidylinositol to retard senescene and to enhance fruit ripening
Inventor: PALTA JIWAN PAUL
IPC: A23L3/3553
Filed: 1998-11-09
Abstract: A method of delaying senescence in fruit and other plant tissues, the method comprising the step of applying to fruit or other plant tissues a composition comprising lysophosphatidylinositol, lysophosphatidylethanolamine (18:1) or combinations thereof.
Patent NZ-505238-A (NZ)
Title: An assay to determine the binding of a mutein with an IL-4Ralpha
Inventor: GREVE JEFFREY
IPC: A61K38/20
Filed: 1997-07-09
Abstract: An assay for determining the ability of a mutein to bind to a receptor, comprising steps of: (a) introducing into a scintillant-coated microplate with streptavidin the binding portion of a receptor chain which has a peptide tag capable of being bound by streptavidin; (b) introducing into the scintillant-coated microplate a radiolabelled native ligand having an affinity for the binding portion of the receptor chain; (c) introducing into the scintillant-coated microplate a mutein ligand having an affinity for the binding portion of the receptor chain; (d) measuring the amount of signal given off by the scintillant-coated microplate after allowing for equilibration; and (e) calculating the affinity of the mutein ligand versus the native ligand. The method preferably uses the receptor chain IL-4Rá.
Patent NZ-507455-A (NZ)
Title: Levosimendan composition with alginic acid as a stability improving agent
Inventor: LARMA ILKKA
IPC: A61P9/04
Filed: 1999-04-23
Abstract: The composition of levosimendan ([[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile) and alginic acid is formulated for oral administration, in the form of tablets, dragees, capsules, powders or granules.  The amount of levosimendan in the composition is from 0.1 to 20 % per weight of the composition, and the amount of alginic acid is preferably 10-40 % per weight of the composition.
Patent NZ-507694-A (NZ)
Title: Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
Inventor: ARMOUR KATHRYN LESLEY
IPC: A61K48/00
Filed: 1999-05-07
Abstract: Disclosed are binding molecules which are recombinant polypeptides comprising: (i) a binding domain capable of binding a target molecule, and (ii) an effector domain having an amino acid sequence substantially homologous to all or part of a constant domain of a human immunoglobulin heavy chain.  Each binding molecule is capable of binding the target molecule without triggering significant complement dependent lysis, or cell mediated destruction of the target, and wherein the effector domain is capable of specifically binding FcRn and/or Fc gamma RIIb.  These are generally based on chimeric domains, which are derived from two or more human immunoglobulin heavy chain CH2 domains.  In preferred embodiments the regions 233-236, and 327-331 are modified, as are further residues to render the molecule null allotypic.  The binding domain may derive from any source appropriate to the (usually clinical) application for the molecule and may be from e.g. an antibody; an enzyme; a hormone; a receptor; a cytokine or an antigen; a ligand and an adhesion molecule.  Also disclosed are nucleic acids, host cells, production processes and materials, and uses e.g. to inhibit B cell activation; mast cell degranulation; phagocytosis, or to inhibit the binding of a second binding molecule to the target molecule.  Pharmaceutical preparations are also disclosed.
Patent NZ-508561-A (NZ)
Title: Broadcast service access control
Inventor: RAITH KRISTER ALEX
IPC: H04L29/06
Filed: 1999-05-28
Abstract: A method for controlling access to a broadcast information service in a radio communication system comprises: encrypting information associated with the broadcast information service; broadcasting the encrypted information over an air interface, wherein the encrypted information is available to a plurality of remote stations; encrypting a service key for transmission using encryption derived from an A-key, wherein the A-key is derived by a receiving station according to information received wirelessly; transmitting the service key usable to decrypt the encrypted information as part of message addressed to one or more subscribing ones of the plurality of remote stations and periodically changing the service key.
Patent NZ-509564-A (NZ)
Title: Method for precipitating hemicellulose onto fibres for improved yield and beatability
Inventor: GUSTAVSSON LENNART
IPC: D21C3/02
Filed: 1999-06-30
Abstract: A method for continuous cooking of lignocellulosic fibre material is disclosed. The method comprises the steps of sequentially (a) in a first stage, impregnating the fibre material in an impregnation liquid comprising alkali metal hydroxide, and thereafter withdrawing a spent impregnation liquid; (b) in a second stage, cooking the fibre material in a cooking liquor comprising alkali metal hydroxide; and (c) in a third stage, adding to said fibre material, a liquid which is rich in hemicellulose, said liquid preferably comprising at least a part of said withdrawn spent impregnation liquid. In a fourth stage (d), the fibre material is cooked in a cooking liquor comprising the liquid added in the third stage, whereby the fibre material is subjected to a retention time of at least 1 hour in said fourth stage.
Patent NZ-511514-A (NZ)
Title: Wettable and erosion/oxidation-resistant carbon-composite materials containing a metal boride
Inventor: MIRTCHI AMIR A
IPC: C04B35/52
Filed: 1999-11-16
Abstract: A process for producing a carbon composite material that in use a cathode or cell lining of an aluminum electrolysis cell contains a metal boride comprises introducing a metal boride precursor mixture into a carbonaceous component to form the carbon composite material.  The metal boride precursor mixture generates metal borides when exposed in the carbonaceous component to start-up and operation conditions of an aluminum electrolysis cell. The precursor mixture can contain born oxide, borax or boric acid with titanium, zirconium, vanadium, hafnium, niobium, tanalum, chromium or molybdenum oxide. The carbonaceous material can be a mixture of pitch and anthracite.
Patent NZ-513681-A (NZ)
Title: Gusseted zipper bag
Inventor: AUSNIT STEVEN
IPC: B65D33/25
Filed: 2001-08-21
Abstract: The gusseted sidewall portions 34, aligned with the zipper interlocking profiles 30, 32 on the insides of the front and rear walls of a plastic bag at the opening of the bag, are thinned so that, when the bag is closed, the thinned areas can be accommodated within the interlocked profiles 30, 32.   The thinning may be accomplished by cutting the portions 34 out of the side walls and covering the resultant windows by profile-free portions of the web bearing the profiles, the web material being thinner than the material cut from the side walls.
Patent NZ-516135-A (NZ)
Title: Non-toxic, microbicidal detergent
Inventor: LEE SEAN
IPC: C11D3/12
Filed: 2000-07-07
Abstract: Nontoxic cleaning agents with biocidal and dirt-removing properties for the conjoint use with a solvent and comprising at least a surface-active agent, characterized in that the nontoxic cleaning agent contains particles of bioactive glass, which, in an aqueous solution, forms a layer of hydroxyl apatite on its surface. Said cleaning agent containing such glass particles not only acts as a biocide against viruses and bacteria, but is also gentle to the skin and to fabrics, causes no allergic reactions and, moreover, is capable of eliminating difficult-to-remove dirt such as aged proteins.
Patent NZ-520662-A (NZ)
Title: PGF2alpha 1-ethanolamide ocular hypotensive lipids
Inventor: WOODWARD DAVID F
IPC: A61K9/00
Filed: 2001-02-05
Abstract: PGF2a 1-ethanolamide compounds of formula 1 that are useful as ocular hypotensive agents but do not exert their activity through the FP prostaglandin receptor are disclosed, wherein the variables are as defined in the specification. In particular the compound PGF2a 1-ethanolamide, having the formula (I) was discovered to be present in mammalian tissue as a naturally occurring substance, was synthesized in a substantially pure form and was found to be effective for lowering intraocular pressure in the mammalian eye, but not acting through the FP receptor through which many ocular hypotensive prostaglandins act.
Patent NZ-521309-A (NZ)
Title: Improvements in or relating to rail mounting
Inventor: TURNER MARK RODNEY
IPC: A47K3/20
Filed: 2002-09-10
Abstract: Methods and apparatus of and for mounting slide rails, stood off from surfaces are disclosed. The method comprises the steps of mounting a first stand-off to a surface by use of a fastener and a taper-lock assembly by attachment into the surface and expansion of the taper-lock against the interior of the first stand-off, locating an end of a rail into the first stand-off, locating the other end of the rail into a second stand-off, and then mounting the second stand-off to the surface by use of a fastener that, within the second stand-off, passes through the rail and into the surface. The apparatus comprises the finished slide rail assembly, the components thereof (in combination, assembly, disassembly or otherwise). The components are a rail, standoffs to receive the rail, a taper-lock assembly, comprising a taper and lock ring, fasteners for attachment, seals to go between the standoffs and wall, caps for the standoffs and a plug that may be installed into a redundant mounted plumbing fitting, behind, in or on the wall, into which a fastener can be penetratively fastened to hold at least part of the slide assembly to the wall.
Patent NZ-522793-A (NZ)
Title: Aryl and heteroaryl diazabicycloalkanes, their preparation and use
Inventor: PETERS DAN
IPC: A61P25/36
Filed: 2001-06-20
Abstract: Disclosed are 3,9-diazabicylo-[4.2.1]-nonane compounds of formula (I), wherein: n is 2, m is 1, one of R and R1 is H or alkyl, and the other of R and R1 is phenyl or naphthyl which may be substituted once or twice with alkoxy, halogen, trihalogenmethyl and/or trihalogenmethoxy, or the other of R and R1 is a quinolinyl which may be substituted once or twice with alkoxy, halogen, trihalogenmethyl and/or trihalogenmethoxy. The compounds are used in the manufacture of medicaments for the treatment of diseases responsive to modulation of cholinergic receptors and/or monoamine receptors.
Patent NZ-523964-A (NZ)
Title: Opioid dosage forms that prevent abuse of the opioid active
Inventor: PALERMO PHILLIP
IPC: A61K31/485
Filed: 2003-01-31
Abstract: An opioid analgesic dosage form to reduce the abuse potential of the active opioid analgesic, comprising an analgesically effective amount of an orally active opioid agonist combined with an opioid antagonist so that at least a two-step extraction process would be required to separate the combination, the amount of opioid antagonist including being sufficient to counteract opioid effects if extracted together with the opioid agonist and administered parenterally.
Patent NZ-529631-A (NZ)
Title: Indole derivatives with 5-hydroxytryptamine (5-HT) 5-HT6 receptor affinity in the treatment of disorders of the CNS
Inventor: BEARD COLIN CHARLES
IPC: A61P25/28
Filed: 2002-05-29
Abstract: Disclosed herein is a compound of formula (I), and a pharmaceutical composition comprising said compound for use in the manufacture of a medicament for the treatment or prevention of a disease state that is alleviated by 5-HT6 agonists.
Patent NZ-537878-A (NZ)
Title: Drive unit mount for reciprocating slat conveyor
Inventor: FOSTER RAYMOND KEITH
IPC: B65G25/06
Filed: 2005-01-25
Abstract: A mounting frame for an assembly of linear hydraulic motors each having a cylinder component and a piston component. Transverse frame members (14, 16) extend across and are connected to longitudinal frame members (10, 12). Frame member (14) divides longitudinal frame members (10, 12) into major and minor parts (20, 22, 24, 26). The minor parts (24, 26) are braced by gussets (70, 72) which extend between the minor parts (24, 26) and a vertical web portion (68) of the traverse beam (14). The minor parts (24, 26) of the frame members (10, 12) and the central portion of the frame member (14) form a nook (76) in the cylinder components (80, 82, 84, 102, 104). Piston rod portions (92, 94, 96) of the assembly of linear motors extend from the cylinder component portions to guide bearings (100) mounted in openings (56, 58, 60) formed in the vertical web (54) of the second transverse beam (16). Bolts are used to connect the inner corner portions of the assembly of linear hydraulic motors to mounting pads (34, 36). More bolts are used to connect the outer corner portion of the cylinder components to mounting lugs (38, 40).
Patent NZ-539771-A (NZ)
Title: Tuning methods and apparatus for inductively coupled power transfer (ICPT) systems
Inventor: BOYS JOHN TALBOT
Filed: 2005-04-29
Abstract: A method for controlling a resonant circuit of an ICPT system is disclosed. The method includes the steps of (a) introducing a predetermined perturbation in a magnitude of a variable reactance in the resonant circuit, (b) sensing a change in a property of the resonant circuit in response to the perturbation, and, (c) varying the variable reactance to alter the resonant frequency of the circuit in response to the sensed change.
Patent NZ-542349-A (NZ)
Title: Stopper of vessel
Inventor: RHO HEE KWON
IPC: B65D51/18
Filed: 2004-02-14
Abstract: A vessel stopper comprises: a body mounted at a vessel opening through which contents stored in a vessel are discharged outwardly, and having a space therein; a mounting unit formed at a lower side of the body, for mounting the body at the vessel opening; and a sealing member removing unit formed in the body, for removing a sealing member sealed at the vessel opening and thereby storing the sealing member in the body when the body is detached from the vessel opening.
Patent NZ-545875-A (NZ)
Title: Quick-release drill guide assembly for bone plate
Inventor: BINDER LAWRENCE J
IPC: A61B17/00
Filed: 2004-08-13
Abstract: The present disclosure relates to a surgical drill-guide assembly that can be releasably attached to a part of a bone-fixation system, for example, a plate. The surgical drill-guide assembly of the present invention is used for example, to guide a drill, screw, bone fastener, or other instrument or fastener into bone.
Patent NZ-546728-A (NZ)
Title: Gaming apparatus having a game event monitor and a event guarantee component
Inventor: ELLIS BENJAMIN JAMES
IPC: A63F13/00
Filed: 2004-10-13
Abstract: A gaming apparatus includes a component for monitoring gameplay; a component for monitoring the occurrence of a game event; an event guarantee component for guaranteeing that a game event will trigger within a set amount of gameplay and an indicator component for indicating the amount of gameplay remaining to be played before a guaranteed game event will trigger. The event guarantee component includes a trigger component for triggering a game event when the set guarantee gameplay amount is reached without the monitored event having been triggered.
Patent NZ-548260-A (NZ)
Title: Improvements in watercraft
Inventor: ROAKE QUENTIN PAUL
Filed: 2006-06-30
Abstract: A multi hulled watercraft made up by joining together at least two single hulled watercraft, each of which has a hull 1 formed primarily of a lightweight synthetic material and an outrigger. One end of the outrigger is attached to the hull and can be removed, and at the other end is a float. The multi hulled watercraft is made by removing the floats from the outriggers, and using the outriggers 3 to extend between and couple the hulls together.
Patent NZ-548319-A (NZ)
Title: Benzimidazole derivatives
Inventor: GERSPACHER MARC
IPC: A61K31/4184
Filed: 2005-01-13
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification, and processes for its preparation. The compounds are benzimidazole derivatives that promote parathyroid hormone (PTH) release useful in the treatment of conditions of bone which are associated with increased calcium depletion or resorption, or in which stimulation of bone formation and calcium fixation in the bone is desirable.
Patent NZ-549687-A (NZ)
Title: Infectious bursal disease virus antigenic isolates and vaccines
Inventor: RODENBERG JEFFREY HAROLD
IPC: C07K14/08
Filed: 2005-03-10
Abstract: Provided is a vaccine composition comprising an lnfectious Bursal Disease Virus (IBDV) VP-2 antigen and a pharmacologically acceptable carrier, wherein said IBDV VP-2 antigen comprises a specified classic consensus sequence with two or more amino acid substitutions; wherein a first amino acid substitution of G to D at amino acid position 318 is the only amino acid substitution within the major hydrophilic peak B of IBDV VP-2; and wherein a second amino acid substitution is selected from the group consisting of 222-T, 249-K, 254-S, 279-N and 286-1. Further provided are compositions comprising at least one additional poultry antigen, which can be a reovirus, and a vaccine composition comprising an antigenic isolate ATCC Accession # PTA-5848. Also provided are methods of inducing protection against IBDV using the said compositions.
Patent NZ-551369-A (NZ)
Title: A cheese flavor composition and process for making same
Inventor: KOKA RAMARATHNA
IPC: A23L29/00
Filed: 2006-11-17
Abstract: Disclosed is a method for accelerating development of cheese flavour for use in edible food products comprising the steps of, (a) contacting a protein containing dairy product with a lactic acid culture to form a reaction mixture at a temperature of about 25 to about 45 degrees C for about 8 to about 72 hours to provide peptides and free amino acids; (b) contacting the peptides and free amino acids with amino acid oxidase to deaminate the peptides and free amino acids to provide alpha-keto acids; wherein the alpha-keto acids are further metabolized within the reaction mixture to provide flavour compounds.
Patent NZ-554267-A (NZ)
Title: Adjustable drain loop for urine collection system
Inventor: TULLY STEPHEN
Filed: 2007-04-02
Abstract: A urine collection system (10) with an adjustable length drain tube (12) is disclosed. A clip (100) is used to form a selectively adjustable loop in the drain tube. The clip has at least one pair of arms that extend from a base. The arms have an inner gripping surface to retain a first section of drain tube in an adjacent relationship with a second section of drain tube, while still allowing for adjustment of the tube within the clip.
Patent NZ-560482-A (NZ)
Title: An apparatus and method of ultrasonic cleaning and disinfection using a distensible bladder between two liquids
Inventor: MCLOUGHLIN ARTHUR R
IPC: A61L2/025
Filed: 2006-02-08
Abstract: Disclosed is an ultrasonic apparatus for cleaning and disinfection. The apparatus includes: a sonotrode (10) at least substantially surrounded by a distensible bladder (20); an ultrasonic generator (45) connected to the sonotrode; and an ultrasonic transducer connected to the ultrasonic generator and associated with the sonotrode. When the apparatus is in use the sonotrode is placed within the inside of a container (30) containing a first liquid (L1), with the sonotrode being at least partially surrounded by a second liquid (L2), and the bladder being positioned between the first and second liquids so that the sonotrode shaft is in direct contact with the second liquid and not the first liquid.
Patent NZ-561147-A (NZ)
Title: System and method for controlling access to features of a medical instrument
Inventor: BATCH RICHARD M
IPC: G06F21/30
Filed: 2006-03-03
Abstract: A system for controlling access to operating features of a medical instrument that has a plurality of operating features is disclosed. The system comprises an input device, an access key, and a controller. An operator may provide control signals for the operation of the medical instrument using the input device, the control signals including selection signals to select single features or combinations of features for operation of the medical instrument. The access key has an access component and a feature control component, where the feature control component includes a data area indicating which of the operating features are to be activated or deactivated. The controller is responsive to the access key to determine if the access component is acceptable and if so, to enable and disable particular operating features of the medical instrument in accordance with the data area of the feature control component of the access key. The controller is responsive to control signals from the input device to permit operator control over such enabled features and does not permit operator control over such disabled features.
Patent NZ-565187-A (NZ)
Title: Limb compression device with control system
Inventor: BONNEFIN WAYNE LEE
IPC: A61H23/00
Filed: 2006-07-20
Abstract: A compression device for a limb of a patient comprises an inflatable sleeve (2) arranged to surround the limb and a conduit (10) attached to the sleeve (2) arranged to deliver fluid to the sleeve (2). The device also comprises a control system arranged to control fluid flow in the device and a memory (not shown) arranged to store gathered data relating to use of the device.